Your browser doesn't support javascript.
loading
Dapagliflozin and Recurrent Heart Failure Hospitalizations in Heart Failure With Reduced Ejection Fraction: An Analysis of DAPA-HF.
Jhund, Pardeep S; Ponikowski, Piotr; Docherty, Kieran F; Gasparyan, Samvel B; Böhm, Michael; Chiang, Chern-En; Desai, Akshay S; Howlett, Jonathon; Kitakaze, Masafumi; Petrie, Mark C; Verma, Subodh; Bengtsson, Olof; Langkilde, Anna-Maria; Sjöstrand, Mikaela; Inzucchi, Silvio E; Køber, Lars; Kosiborod, Mikhail N; Martinez, Felipe A; Sabatine, Marc S; Solomon, Scott D; McMurray, John J V.
Afiliação
  • Jhund PS; BHF Cardiovascular Research Centre, University of Glasgow, United Kingdom (P.S.J., K.F.D., M.C.P., J.J.V.M.).
  • Ponikowski P; Center for Heart Diseases, University Hospital, Wroclaw Medical University, Poland (P.P.).
  • Docherty KF; BHF Cardiovascular Research Centre, University of Glasgow, United Kingdom (P.S.J., K.F.D., M.C.P., J.J.V.M.).
  • Gasparyan SB; Late Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden (S.B.G., O.B., A.-M.L., M.S.).
  • Böhm M; The Department of Medicine, Saarland University Hospital, Homburg-Saar, Germany (M.B.).
  • Chiang CE; Division of Cardiology, Taipei Veterans General Hospital and National Yang-Ming University, Taiwan (C.-E.C.).
  • Desai AS; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA (A.S.D., S.D.S.).
  • Howlett J; Cumming School of Medicine and Libin Cardiovascular Institute, University of Calgary, Alberta, Canada (J.H.).
  • Kitakaze M; Cardiovascular Division of Medicine, National Cerebral and Cardiovascular Center, Osaka, Japan (M.K.).
  • Petrie MC; BHF Cardiovascular Research Centre, University of Glasgow, United Kingdom (P.S.J., K.F.D., M.C.P., J.J.V.M.).
  • Verma S; Division of Cardiac Surgery, St. Michael's Hospital, University of Toronto, Canada (S.V.).
  • Bengtsson O; Late Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden (S.B.G., O.B., A.-M.L., M.S.).
  • Langkilde AM; Late Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden (S.B.G., O.B., A.-M.L., M.S.).
  • Sjöstrand M; Late Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden (S.B.G., O.B., A.-M.L., M.S.).
  • Inzucchi SE; Section of Endocrinology, Yale School of Medicine, New Haven, CT (S.E.I.).
  • Køber L; Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Denmark (L.K.).
  • Kosiborod MN; Saint Luke's Mid America Heart Institute, University of Missouri, Kansas City (M.N.K.).
  • Martinez FA; The George Institute for Global Health, University of New South Wales, Sydney, Australia (M.N.K.).
  • Sabatine MS; Universidad Nacional de Córdoba, Argentina (F.A.M.).
  • Solomon SD; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA (M.S.S.).
  • McMurray JJV; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA (A.S.D., S.D.S.).
Circulation ; 143(20): 1962-1972, 2021 05 18.
Article em En | MEDLINE | ID: mdl-33832352

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos Benzidrílicos / Inibidores do Transportador 2 de Sódio-Glicose / Glucosídeos / Insuficiência Cardíaca Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Aged / Female / Humans / Male Idioma: En Revista: Circulation Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos Benzidrílicos / Inibidores do Transportador 2 de Sódio-Glicose / Glucosídeos / Insuficiência Cardíaca Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Aged / Female / Humans / Male Idioma: En Revista: Circulation Ano de publicação: 2021 Tipo de documento: Article